AKT signaling in regulating angiogenesis

被引:167
作者
Jiang, Bing-Hua [1 ]
Liu, Ling-Zhi [2 ,3 ]
机构
[1] Nanjing Med Univ, Lab Reproduct Med, Ctr Canc, Nanjing 210029, Peoples R China
[2] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA
[3] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA
关键词
AKT; VEGF; HIF-1; tumor growth; vascularization; angiogenesis;
D O I
10.2174/156800908783497122
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AKT is a central signaling molecule in regulating cell survival, proliferation, tumor growth and angiogenesis. Upstream components of AKT signaling pathway such as PI3K, PTEN, and Ras are commonly mutated in many human cancers. Recently it is found that AKT plays an important role in regulating normal vascularization and pathological angiogenesis. Angiogenesis is required for tumor growth and metastasis when tumor reaches more than 1 mm in diameter. This review focuses on the role and potential mechanism of AKT signaling in regulating angiogenesis. Recent studies have shown that AKT activation is necessary and sufficient to regulate VEGF and HIF-1 expression in human cancer cells. VEGF and HIF-1 are potent inducers of angiogenesis. It was found that AKT activation induces VEGF and HIF-1 expression through its two downstream molecules HDM2 and p70S6K1. On the other hand, AKT transmits the upstream signals from growth factors, cytokines, heavy metals, and oncogenes for regulating VEGF and HIF-1 expression in human cancer cells. AKT activation and VEGF expression can be inhibited by different natural compounds used for cancer prevention. Thus, inhibition of AKT and its downstream targets offers a new approach for targeting angiogenesis, which could be important for the development of new cancer therapeutics in the future.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 141 条
[1]   Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis [J].
Ackah, E ;
Yu, J ;
Zoellner, S ;
Iwakiri, Y ;
Skurk, C ;
Shibata, R ;
Ouchi, N ;
Easton, RM ;
Galasso, G ;
Birnbaum, MJ ;
Walsh, K ;
Sessa, WC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :2119-2127
[2]   Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro:: Possible involvement of inhibition of survival signal transduction pathways [J].
Akimoto, T ;
Nonaka, T ;
Ishikawa, H ;
Sakurai, H ;
Saitoh, J ;
Takahashi, T ;
Mitsuhashi, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (01) :195-201
[3]   Mechanism of activation and function of protein kinase B [J].
Alessi, DR ;
Cohen, P .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) :55-62
[4]   Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity [J].
Bagli, E ;
Stefaniotou, M ;
Morbidelli, L ;
Ziche, M ;
Psillas, K ;
Murphy, C ;
Fotsis, T .
CANCER RESEARCH, 2004, 64 (21) :7936-7946
[5]   Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1α expression [J].
Bárdos, JI ;
Chau, NM ;
Ashcroft, M .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2905-2914
[6]   MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS [J].
BELLACOSA, A ;
DEFEO, D ;
GODWIN, AK ;
BELL, DW ;
CHENG, JQ ;
ALTOMARE, DA ;
WAN, MH ;
DUBEAU, L ;
SCAMBIA, G ;
MASCIULLO, V ;
FERRANDINA, G ;
PANICI, PB ;
MANCUSO, S ;
NERI, G ;
TESTA, JR .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) :280-285
[7]  
BROWN LF, 1993, CANCER RES, V53, P4727
[8]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[9]   PROTEIN-KINASE-B (C-AKT) IN PHOSPHATIDYLINOSITOL-3-OH INASE SIGNAL-TRANSDUCTION [J].
BURGERING, BMT ;
COFFER, PJ .
NATURE, 1995, 376 (6541) :599-602
[10]   Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF) [J].
Byrne, AM ;
Bouchier-Hayes, DJ ;
Harmey, JH .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2005, 9 (04) :777-794